Daniel Clark - Aug 11, 2022 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBP)

Role: Chief Financial Officer
Signature: /s/ Daniel Clark
Stock symbol: KRBP
Transactions as of: Aug 11, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/15/2022, 04:26 PM
Previous filing: Oct 14, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRBP	Common Stock	Award	$0	+50K	+391.54%	$0.00	62.8K	Aug 11, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") and will be settled in common stock as soon as practicable within 60 days following vesting. The RSUs were granted pursuant to an executive employment agreement entered into by and between the reporting person and the issuer dated February 14, 2022, pursuant to which the reporting person was entitled to receive a grant of 150,000 RSUs. For the purpose of managing the issuer's equity incentive plan pool, the reporting person and the issuer agreed that 50,000 RSUs would be granted on August 11, 2022, vesting immediately, and the remaining 100,000 RSUs would be granted as soon as the issuer deems appropriate and practical.
F2	Includes (i) 50,000 shares of common stock underlying the RSUs, (ii) 6,866 shares of common stock and (iii) 5,904 shares of restricted stock.

Content

These shares represent restricted stock units ("RSUs") and will be settled in common stock as soon as practicable within 60 days following vesting. The RSUs were granted pursuant to an executive employment agreement entered into by and between the reporting person and the issuer dated February 14, 2022, pursuant to which the reporting person was entitled to receive a grant of 150,000 RSUs. For the purpose of managing the issuer's equity incentive plan pool, the reporting person and the issuer agreed that 50,000 RSUs would be granted on August 11, 2022, vesting immediately, and the remaining 100,000 RSUs would be granted as soon as the issuer deems appropriate and practical.

Includes (i) 50,000 shares of common stock underlying the RSUs, (ii) 6,866 shares of common stock and (iii) 5,904 shares of restricted stock.